ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FDBK Feedback Plc

62.50
-5.00 (-7.41%)
23 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00 -7.41% 62.50 60.00 65.00 67.50 60.00 67.50 57,620 15:56:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.86 8.33M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 67.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.33 million. Feedback has a price to earnings ratio (PE ratio) of -2.86.

Feedback Share Discussion Threads

Showing 12401 to 12422 of 14850 messages
Chat Pages: Latest  498  497  496  495  494  493  492  491  490  489  488  487  Older
DateSubjectAuthorDiscuss
15/11/2021
14:46
It does seem that way, Pete and if as Yump said earlier there can't be an announcement because there's nothing concrete then perhaps work is being done behind the scenes.

No doubt the company are aware of the speculation but no tweets from Bleepa or Walbrook.

ged5
15/11/2021
14:02
Ladies and gents on 10th Nov Sajid Javid gave a speech at the NHS Confederation Integrated Care System Leaders conference.I quote.And soon, I'll be bringing forward a White Paper on Integration, with our proposals for how health and care can work better as one. It will see us embrace new ways of sharing records and delivering digital services together, for example. It will also see us embrace new approaches to the workforce. Not only helping staff move from sector to sector but also to promote more joint roles across health and social care..Full transcripthttps://www.gov.uk/government/speeches/nhs-confederation-integrated-care-system-leaders-conference
ragnarr
15/11/2021
13:34
Market makers clearly scratching their heads, look at that spread.
petekand
15/11/2021
13:33
Wow beautiful research chaps.
The more I read, the more I become a believer in that this is indeed Bleepa.
I would like to see the volume at 20mill plus though, where is the herd when needed?

petekand
15/11/2021
11:34
Interestingly the actual Govt press release talks about the image sharing technology as the main recipient of the funding with i refer as secondaryhttps://www.gov.uk/government/news/250-million-in-nhs-technology-to-modernise-diagnosticsDiagnostics services across the NHS will be digitalised using the latest technology to improve the way tests, images and results can be shared across computer systems in hospitals, labs and GP surgeries. It means the nurses, doctors and other clinicians caring for a patient can access these results more quickly and easily, even if they are working from different settings.The new technology will allow imaging specialists – the experts analysing a scan or x-ray and providing a diagnosis – to review high-res images remotely without needing to be in an imaging lab, 24 hours a day.The funding will also provide a new tool to help GPs and other clinicians choose the most suitable scan for their patient based on the patient's symptoms and medical history. This will cut inappropriate requests made to radiology departments, saving radiologists' time and ensuring patients get the right scans at the right time.
ragnarr
15/11/2021
10:54
The irefer software is provided by medcurrent and looks like this latest info is what the RCR were alluding to.This software is purely a clinical decision support tool - it has no way of enhancing the way tests, images and results are shared across systems in hospitals, labs and GP practice.https://www.prweb.com/releases/medcurrents_radiology_clinical_decision_support_solutions_now_available_on_epics_app_orchard/prweb18247903.htm
ragnarr
15/11/2021
10:48
Do I feel lucky ? There is potentially a big binary bet if its boot-filling time. If the second one is really Bleepa/Carelocker and a contract gets signed, with those levels of financial support available, the share price is likely to go ballistic. If its not, it would be some more money tied up in a long grind.
yump
15/11/2021
10:40
Ptolemy, I have reason to believe someone from the company does read this thread on occasion as they do on another company where I started a thread.

Well at least that's 12 more days than Cox does on his MP work. You were concerned that FDBK had no NEDs with commercial experience. Are these two not good enough for you?

Just in case this got lost over the weekend:-

Some very positive comments about FDBK from about 20:50



This podcast was from yesterday.

For clarification the software mentioned in the Pulse article was iReferCDS. It reads to me that two pieces of software are being funded.

ged5
15/11/2021
09:43
I filled out my application form for my open offer pplication (paper certificate holding) over the weekend, I see that the open offer shares come with generous EIS tax breaks for qualifying UK tax payers, so on that basis I have applied for a 40X excess over my basic entitlement.

I suspect there will be a fairly substantial scale back in the open offer, so would be quite happy if I end up with a 15X excess which would effectively double my stake.

The EIS tax relief means that eligble shareholders should receive 30p back for every pound invested, plus all gains will be tax free (even if held outside of an ISA or SIPP) and if it all goes wrong, there is the potential to claim back up a further 28p for every pound invested in loss relief

timbo003
15/11/2021
09:40
Some good posts over the w/e.

Ged re. #8947. On the one hand it would be reassuring to know they read such sources. On the other hand I read NED's generally only work 12 days per year, one day a month!

ptolemy
15/11/2021
08:59
A lot of excitement over the weekend (well for me anyway). Still believe Bleepa is being mentioned.

No confirmation anywhere yet.

ged5
14/11/2021
17:16
Herb there are 2 pieces of software being funded

iRefer helps referring GPs, radiographers, clinicians and other healthcare professionals to determine the most appropriate imaging investigation(s) or intervention for patients. It provides practical guidance based on the best available evidence.

Bleepa is the only CE/UKCA-accredited clinical communications platform on the NHSX clinical communications framework that shares images

ged5
14/11/2021
17:11
Thank you.

More on the Sunday Roast for Feedback. Some very positive comments from about 20:50

ged5
14/11/2021
17:10
Ragnarr could it be the Irefer tool?
herb clark
14/11/2021
14:10
I know - felt it deserved an answer :-)
ragnarr
14/11/2021
12:53
Exactly Ragnarr.

The question was rhetorical but until I see the RNS I'm not building up my hopes cos this is big!

ged5
14/11/2021
12:14
The funding news clearly came out on 8th Nov - its all over the place

Ged - in answer to your question :
.
There is only one CE/UKCA-accredited communications platform on the NHSX clinical communications framework.

.

.

.

.

.

ragnarr
14/11/2021
10:54
Hi Ged / Ragnarr,
You've both been busy this weekend. Sounds very exciting.

In answer to your question Ged, the pharmaphorum article was published on the 8th November and was also updated on the 12th November.

You can get this information from the source code of the article which can be obtained using 'Ctrl + U' keys on your PC.

lr2
14/11/2021
10:44
Ptolemy, post 8913.

Just wondering if this tweet was in answer to your question:-



And this is the Feedback team:-



Adam Denning

Non-Executive Director

Adam spent 25 years at Microsoft Corporation in various roles. From 2011-2017, he was a Partner Group Program Manager. In this role, he reported directly to the Corporate VP of the Windows platform, leading an international team of over 100 people and executing updates to Windows to deliver new customers. Before then, from 1999-2001, he served as an Assistant Technical Advisor to the Executive Office, presenting “demo days”, where he would demonstrate internal and external technology to Bill Gates and attending all of his product reviews.

Phillipp Prince

Non-Executive Director

Philipp is a chartered accountant with extensive experience in senior finance roles in both private and listed technology companies. He runs his own financial consultancy business, is a board adviser at Overmore Limited, a marketing technology firm, and recently joined BCB Group Holdings Limited, a financial services challenger, as its non-board CFO.
He was previously the CFO of Defenx plc, an AIM-listed mobile cyber security company, where he managed the IPO process, fundraising and investor relations and Interim CFO at Enecsys plc, a private equity backed solar micro-inverter developer. For over 20 years, Philipp worked at BDO LLP, where he was a corporate finance partner from 2002-2013.

ged5
14/11/2021
10:25
Ragnarr, many thanks for your research recently. Did you notice when the pharmaphorum article was published?

The Pulse article looks like it was uploaded round about the time the market closed on Friday. Just wondering if there'll have to be an announcement in the morning.

ged5
14/11/2021
09:13
If this is Bleepa the share price could go ballistic!
herb clark
14/11/2021
08:03
It must Ged, unless we have a competitor that we don’t know about.
ducatiman
Chat Pages: Latest  498  497  496  495  494  493  492  491  490  489  488  487  Older

Your Recent History

Delayed Upgrade Clock